Bank of America’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Buy |
14,350
+7,295
| +103% | +$72.9K | ﹤0.01% | 5374 |
|
|
2025
Q1 | $620K | Buy |
7,055
+453
| +7% | +$39.8K | ﹤0.01% | 4624 |
|
|
2024
Q4 | $612K | Sell |
6,602
-856
| -11% | -$79.4K | ﹤0.01% | 4574 |
|
|
2024
Q3 | $546K | Buy |
7,458
+6,911
| +1,263% | +$506K | ﹤0.01% | 4613 |
|
|
2024
Q2 | $31.8K | Buy |
547
+292
| +115% | +$17K | ﹤0.01% | 5771 |
|
|
2024
Q1 | $264K | Sell |
255
-394
| -61% | -$407K | ﹤0.01% | 4914 |
|
|
2023
Q4 | $514K | Buy |
649
+355
| +121% | +$281K | ﹤0.01% | 4605 |
|
|
2023
Q3 | $140K | Buy |
294
+114
| +63% | +$54.2K | ﹤0.01% | 5231 |
|
|
2023
Q2 | $108K | Sell |
180
-200
| -53% | -$120K | ﹤0.01% | 5321 |
|
|
2023
Q1 | $268K | Buy |
380
+164
| +76% | +$116K | ﹤0.01% | 4999 |
|
|
2022
Q4 | $221K | Sell |
216
-148
| -41% | -$152K | ﹤0.01% | 5131 |
|
|
2022
Q3 | $211K | Buy |
364
+306
| +528% | +$177K | ﹤0.01% | 5155 |
|
|
2022
Q2 | $32K | Sell |
58
-59
| -50% | -$32.6K | ﹤0.01% | 6214 |
|
|
2022
Q1 | $75K | Sell |
117
-155
| -57% | -$99.4K | ﹤0.01% | 6215 |
|
|
2021
Q4 | $112K | Buy |
272
+247
| +988% | +$102K | ﹤0.01% | 6000 |
|
|
2021
Q3 | $18K | Buy |
+25
| New | +$18K | ﹤0.01% | 6510 |
|